Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 15/20 | 0.46 |
| ▸ | HTR3A | P46098 | 2/20 | 0.44 |
| ▸ | UGCG | Q16739 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6849531 | 0.91 | CHRNA7 (0.41) | CHRNA7HTR3AUGCGCHRNB2CHRNA4 | |
| SCHEMBL6008657 | 0.83 | CHRNA7 (0.65) | CHRNA7HTR3AUGCG | |
| SCHEMBL6008770 | 0.83 | CHRNA7 (0.65) | CHRNA7HTR3AUGCG | |
| SCHEMBL842326 | 0.83 | CHRNA7 (0.59) | CHRNA7HTR3AUGCG | |
| Hydrochloric Acid SCHEMBL6008611 | 0.83 | CHRNA7 (0.64) | CHRNA7HTR3AUGCG | |
| SCHEMBL6008407 | 0.82 | CHRNB2 (0.51) | CHRNA7HTR3ACHRNB2CHRNA4KCNH2 | |
| SCHEMBL6849884 | 0.78 | CHRNA7 (0.60) | CHRNA7HTR3A | |
| SCHEMBL6498593 | 0.76 | SMN1; SMN2 (0.49) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6489819 | 0.75 | MEN1 (0.49) | CHRNA7CHRNB2CHRNA4 | |
| SCHEMBL6496731 | 0.75 | CHRNA7 (0.42) | CHRNA7HTR3ACHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1432707-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-06-30 | — | — | EP | claimed |
| WO-2003029252-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2003-04-10 | — | — | WO | claimed |
| EP-1432707-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003029252-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2003-04-10 | — | — | WO | disclosed |